Bioscience ClubhouseCT Features: The Story of Cybrexa with Per Hellsund, President & CEO
Cybrexa Therapeutics is an oncology-focused biotechnology company working to create novel therapeutics with a markedly enhanced therapeutic index. Its first class of new agents will target DNA repair, with a focus on the creation of new classes of radio- and chemo-sensitizers, which will target a wide range of solid tumors. These new agents will allow the […]